Allspring Global Investments Holdings, LLC Uro Gen Pharma Ltd. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$12.72 - $19.2 $4,261 - $6,432	335 Added 6.75%	5,298 $88,000
Q1 2024 Apr 18, 2024	BUY	$13.81 - $19.33 $110 - $154	8 Added 0.16%	4,963 $74,000
Q4 2023 Jan 25, 2024	BUY	$10.87 - $15.93 $12,946 - $18,972	1,191 Added 31.64%	4,955 $74,000
Q3 2023 Oct 27, 2023	BUY	$8.84 - $22.64 $33,273 - $85,216	3,764 New	3,764 $52,000
Q2 2022 Jul 25, 2022	SELL	$5.12 - $8.74 $244,367 - $417,142	-47,728 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$5.92 - $9.73 $40,812 - $67,078	6,894 Added 16.88%	47,728 $415,000
Q4 2021 Jan 28, 2022	BUY	$9.03 - $19.13 $368,731 - $781,154	40,834 New	40,834 $388,000

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account